Tumor Ablation Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Technology (Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others), Application (Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others), Mode of Treatment (Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others), and Geography
Report Code: TIPHE100001314 No. of Pages: 150 Category: Medical Device Status: Upcoming
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
Tumor Ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to "burn" or "freeze" cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor.
The tumor ablation market is anticipated to grow with a significant rate in the coming years, owing to factors such as, Increasing prevalence of cancer in the global population. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for tumor ablation market.
The "Global Tumor Ablation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global tumor ablation market with detailed market segmentation by technology, application, mode of treatment, and geography. The global tumor ablation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the tumor ablation market.
The global tumor ablation market is segmented on the basis of technology, application, mode of treatment, and geography. Based on technology, the market is segmented as, cryoablation, radiofrequency (RF) ablation, microwave ablation and others. The application segment includes, lung cancer, liver cancer, kidney cancer, bone metastasis and others. Based on mode of treatment, the market is segmented as, percutaneous ablation, surgical ablation, laparoscopic ablation and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global tumor ablation market based on technology, application, mode of treatment, and geography. It also provides market size and forecast till 2027 for overall tumor ablation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the tumor ablation market in the coming years, owing to factors such as, enhanced healthcare infrastructure and rising occurrence of cancer in United States and Canada. In addition, increasing health tourism due to inferior treatment charges in Asia Pacific region it is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key tumor ablation market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Healthtronics, Inc., Boston Scientific Corporation, Misonix, Inc., Mermaid Medical A/S, Neuwave Medical, Inc., Medtronic, PLC, Angiodynamics, Inc., Galil Medical, Inc., Edap Tms S.A., Sonacare Medical LLC
The tumor ablation market is anticipated to grow with a significant rate in the coming years, owing to factors such as, Increasing prevalence of cancer in the global population. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for tumor ablation market.
The "Global Tumor Ablation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global tumor ablation market with detailed market segmentation by technology, application, mode of treatment, and geography. The global tumor ablation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the tumor ablation market.
The global tumor ablation market is segmented on the basis of technology, application, mode of treatment, and geography. Based on technology, the market is segmented as, cryoablation, radiofrequency (RF) ablation, microwave ablation and others. The application segment includes, lung cancer, liver cancer, kidney cancer, bone metastasis and others. Based on mode of treatment, the market is segmented as, percutaneous ablation, surgical ablation, laparoscopic ablation and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global tumor ablation market based on technology, application, mode of treatment, and geography. It also provides market size and forecast till 2027 for overall tumor ablation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the tumor ablation market in the coming years, owing to factors such as, enhanced healthcare infrastructure and rising occurrence of cancer in United States and Canada. In addition, increasing health tourism due to inferior treatment charges in Asia Pacific region it is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key tumor ablation market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Healthtronics, Inc., Boston Scientific Corporation, Misonix, Inc., Mermaid Medical A/S, Neuwave Medical, Inc., Medtronic, PLC, Angiodynamics, Inc., Galil Medical, Inc., Edap Tms S.A., Sonacare Medical LLC